Financial Times
UK · 1 hrs ago
Moderna shares soar 90% on melanoma vaccine trial success
Drugmaker’s cancer shot being developed with Merck delivered a positive outcome in a late-stage trial
Do you trust Financial Times?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!